News
Global Cannabis News & Analysis | Business of Cannabis
News · page 62
- Opinion
26-Year-Old Dubliner Becomes Ireland’s First ‘Medical Cannabis Access Programme’ Patient
IRELAND now has its first patient through the state-approved Medical Cannabis Access Programme (MCAP) some four years after it was launched – but experts warn the scheme is still unfit for purpose.
- Companies
From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US.
- News
Danish Cultivator Completes New Facility Gearing Itself For ‘High-Volume Production’
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards profitability, despite reporting no sales and increasing losses in its third quarter.
- CBD Market
Kanavape Duo Have Their Criminal Convictions Overturned After Seven-Year Legal Battle Which Changed The Way Europe Views CBD
A FRENCH court has today overturned the criminal convictions of the two defendants at the centre of the KanaVape case – seven years after they were first charged.
- CBD Market
With Its Stock In Free Fall CBD Firm Chill Brands Looks To Boost ‘Execution’ And ‘Investor Relations’
CHILL Brands Group, a retailer of CBD products in the US, UK and Europe, has seen some £180m wiped off its market value this year.
- News
Irish Clinical Establishment Continues To Shun Cannabis Leaving Medical Access Programme Doomed to Failure
Drug policy specialist Natalie O’Regan on Ireland’s faltering Medical Cannabis Access Programme THE Medical Cannabis Access Programme (MCAP) was launched in 2017, four years later and the first product is now being made available for patients.
- CBD Market
Kanabo Aiming To Become Europe’s First Cannabis ‘Unicorn’
UK Market-listed cannabis business Kanabo is now generating its first revenues following the successful launch of its flagship VapePod product.
- CBD Market
Is CBD A Boom-Or-Bust Fad – Or A Major FMCG Opportunity?
SUGGESTIONS that CBD is a fad – a boom-to-bust market – with the latter imminent, raised a few eyebrows at Cannabis Europa.
- Pharmaceutical
Cannabis Europa – ‘A Melting Pot Of Ideas And Conversations’ – Makes A Successful London Return
STEPHEN Murphy, co-founder and CEO of Prohibition Holdings, kicked-off Cannabis Europa 2021 in central London’s Banking Hall yesterday, welcoming delegates from across Europe and North America, Africa, Asia and Australia.
- Hemp Industry
Why Is Hemp Still Being Politically Sidelined When It Is The Solution To Deforestation?
Rebekah Shaman, Managing Director of the British Hemp Alliance, with an update from COP26 COP26 is probably the most important meeting this decade.
- Pharmaceutical
Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach
THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules.
- News
Portuguese Firm Atann Helps De-Risk Supply Chain Market Entry With ‘One-Stop Shop’
ATANN, a Portuguese company founded in May last year, is poised to become the country’s first cannabis contract manufacturer.
